Objective To retrospective analyze the drug characteristic and clinical effect of Uygur medicine for treating insomnia. Methods Totally 234 cases of insomnia in hospitalized records were selected by record statistical system of HIS. Patients’ general conditions, Uygur medicine utilization rate, combination medication, pathogenic humoral, treatment course and therapeutic effect were retrospectively analyzed. Results Insomnia patients were mainly 30-60 years old (81.82%). Abnormal Sawda and Balgam were the main pathogenic humoral, accounted for 54.27% and 28.63% respectively. And 85 kinds of preparation were involved, including Yinao Wusiti Kudousi syrup and Muniziqii Sawda mixture, 213 and 163 times of frequency (91.03% and 69.66%) respectively. Most of patients used 5-12 kinds of preparation, accounted for 89.13%, and treated for one week to one month, accounted for 73.16%. Conclusion The Uygur medicine for insomnia is unique, and has good clinical efficacy and safety.% 目的回顾性分析维吾尔医药治疗失眠症的用药特点及临床效果。方法通过医院信息病历统计系统，选取诊断为失眠症的234例住院病历，对患者一般情况、维吾尔药使用率、合并用药、致病体液、疗程及治疗效果等进行回顾性分析。结果失眠患者的年龄主要分布在30～60岁之间，占81.82%；异常黑胆质和黏液质为主要致病体液，分别占54.27%、28.63%。所涉及制剂品种85种，其中益脑吾斯提库都斯糖浆使用频次为213次，使用率91.03%；木尼孜其赛吾达合剂使用频次为163次，使用率69.66%；5～12种制剂合并使用的病历数最多，占89.13%；用药天数在7～30 d的病例数占总数的73.16%。结论维吾尔医药治疗失眠症用药独特，具有良好的临床疗效和安全性。
展开▼
